TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC
Clinical trial NCT05250843 · UNKNOWN
Trial details
- NCT number
- NCT05250843
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-30
- Primary completion
- 2023-12-30
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.